SCUR-Alpha 269 GmbH Announces Takeover Offer for CompuGroup Medical

SCUR-Alpha 269 GmbH, soon to be known as Caesar BidCo GmbH, has unveiled its intention to launch a voluntary public takeover offer for CompuGroup Medical SE & Co. KGaA (CGM). The bidder plans to offer a cash consideration of EUR 22.00 per share, which represents a 51% premium over the average trading price of the last three months. The offer targets the approximate 46.16% free float of CGM shares, setting a minimum acceptance threshold of 17% of all issued shares.

A strategic investment agreement has been signed between the bidder, CGM, and key stakeholders, aiming for a potential delisting of CGM post-transaction. The majority shareholder, along with the Gotthardt family, will retain their stakes, having agreed not to participate in the takeover offer.

The offer will be subject to customary conditions, including regulatory approvals, with settlement anticipated in the first half of 2025. Comprehensive details will follow in the official offer document, pending regulatory approvals.